Øresund Pharma ApS: Financial statements 2023
CVR: 39492059
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Øresund Pharma ApS (CVR 39492059) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 38,259,550 and a net result of DKK 16,750,969 compared with DKK 4,302,384 the year before. That is an increase of 121.9% compared with the year before. Equity in the 2023 report amounted to DKK 24,443,398. The solvency ratio was 57.5%. The company had 9 employees in the financial year.
- Gross Profit
- DKK 38,259,550
- Profit/Loss
- DKK 16,750,969
- Equity
- DKK 24,443,398
- Total Assets
- DKK 42,518,117
- Employees
- 9
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 38.3 mio. | 16.8 mio. | 24.4 mio. | 9 |
| 2022 | - | 17.2 mio. | 4.3 mio. | 7.7 mio. | 6 |
| 2021 | - | 7.3 mio. | 281 t. | 3.4 mio. | 5 |
| 2020 | - | 2.8 mio. | -86 t. | 3.1 mio. | 4 |
| 2019 | - | 4.9 mio. | 2.6 mio. | 2.7 mio. | 3 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Øresund Pharma ApS has published its annual report for 2022. Gross profit came to DKK 17,238,144, and the net result was DKK 4,302,384.
About Øresund Pharma ApS
Øresund Pharma ApS is a Danish company of the type Anpartsselskab based in Nordhavn, founded in 2018. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named Øresund Pharma IVS. The management consists of Patrick Halborg Cohn and Svend Aage Johansen. The company is owned by Machpali ApS and ESH Holding 2019 ApS. The company has 21 employees (2026). In 2025, the company reported a gross profit of DKK 39,702,011 and a net result of DKK 6,466,876 compared with DKK 13,707,320 the year before. Equity in the 2025 report amounted to DKK 44,617,595.